Unknown

Dataset Information

0

Inhibition of lipogenesis by halothane in isolated rat liver cells.


ABSTRACT: 1. Halothane at clinically effective concentrations [2.5 and 4% (v/v) of the gas phase of the incubation flask] was found to inhibit significantly lipogenesis from endogenous substrates, e.g., glycogen, or from added lactate plus pyruvate. This was accompanied by a decrease in the ratio of the free [NAD+]/[NADH] of the mitochondrion and the cytoplasm, as shown by the [3-hydroxybutyrate]/[acetoacetate] ratio and the [lactate]/[pyruvate] ratio. 2. Acetoacetate or pyruvate decreased the inhibitory effect of halothane and restored lipogenesis to control rates. They were reduced rapidly by 3-hydroxybutyrate dehydrogenase or lactate dehydrogenase respectively, with the concomitant oxidation of NADH and the generation of NAD+. 3. These results suggest that the mechanism by which halothane inhibits lipogenesis from glycogen or lactate is by inhibition of the oxidation of NADH; this results in inhibition of flux of carbon through pyruvate dehydrogenase and a shortage of acetyl-CoA for fatty acid synthesis. Thus when NADH acceptors are added in the presence of halothane, the concentration of mitochondrial NAD+ is raised so that the flux of carbon through pyruvate dehydrogenase increases and lipogenesis is restored.

SUBMITTER: Mapes JP 

PROVIDER: S-EPMC1164568 | biostudies-other | 1977 Jan

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC2840492 | biostudies-literature
| S-EPMC1161413 | biostudies-other
| S-EPMC1167993 | biostudies-other
| S-EPMC3840356 | biostudies-literature
| S-EPMC3061480 | biostudies-literature
| S-EPMC1168311 | biostudies-other
| S-EPMC1183949 | biostudies-other
| S-EPMC2693465 | biostudies-literature
| S-EPMC3610837 | biostudies-literature
| S-EPMC1173822 | biostudies-other